Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest European Society of Cardiology Stories

2013-06-26 16:41:42

PREFER AF shows European clinicians adhere well to AF guidelines Two important studies were released at the Late Breaking Clinical Trials session II at EHRA EUROPACE 2013. The PREFER AF study2 found that Oral anticoagulation is now used in over 85% of patients with atrial fibrillation (AF) eligible for therapy. And ISSUE (the International Study on Syncope of Uncertain Aetiology) determined that cardiac pacing is more effective in patients with presumed neurally mediated syncope (NMS) and...

2013-06-25 12:44:08

Greater emphasis has been placed on a practical 'how to' approach targeted at generalists, including GPs and geriatricians, as well as expert cardiologists and electro physiologists The 2013 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy┬╣ developed in collaboration with the European Heart Rhythm Association (EHRA), have created a new classification system for bradyarrhythmias according to mechanisms rather than aetiology. The guidelines, presented at the EHRA...

2013-06-24 14:28:49

The EHRA White Book reports on the current status of arrhythmia treatments in the 55 ESC member countries The first European data on lead extraction was released today by the European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC). The information is published in the EHRA White Book 20131, launched at EHRA EUROPACE 2013 in Athens, Greece, during 23-26 June. The EHRA White Book reports on the current status of arrhythmia treatments in the 55 ESC member...

2013-05-27 10:57:22

4-fold increase of andropausal syndrome in men with heart failure Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times more common in men with heart failure. The Heart Failure Congress is the main annual meeting of the Heart Failure Association of the European Society of Cardiology and is being held 25-28 May in Lisbon,...

2013-04-29 20:21:42

WOODBRIDGE, ON, April 29, 2013 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced its operational highlights and financial results for the fiscal year ended December 31, 2012. All dollar amounts referenced herein are in Canadian dollars unless otherwise stated. Financial Review For the twelve months ended December 31, 2012 the...

2013-04-26 09:59:12

Novel treatment has potential in multiple cardiovascular diseases Up to 10 per cent of patients with high blood pressure are resistant to treatment, which puts them at increased risk of cardiovascular events, including heart attacks. Clinical trials show that catheter-based renal denervation reduces blood pressure in patients who do not respond to conventional drug therapy. Use of the technique is increasing in Europe and worldwide and several national societies have published guidance...

2013-02-21 13:19:26

80 percent of all cardiovascular disease is preventable and policies should be encouraged to make healthy choices easy Over eating, sedentary lifestyles, cultural attitudes, and lack of prevention programs are to blame for the rising epidemic of obesity in the Asia Pacific region. Overweight and obesity has quadrupled in China and societies still label people of healthy weight as poor. Prevention will be an important theme at the 19th Asian Pacific Congress of Cardiology held 21-24...

2013-02-13 11:36:03

More than one-third are obese and one-quarter have diabetes With one of the highest rates of obesity in the world, the Gulf region is facing an epidemic of cardiovascular disease. At least 50% of the population is below the age of 25 and the high prevalence of risk factors signals a massive wave of cardiovascular disease in 10-15 years. Cardiovascular centers are already bursting at the seams and prevention services are nonexistent. Prevention will be a key theme at the Saudi Heart...

2012-12-05 14:36:23

Pharmacological stress echo identifies donor hearts that would historically have been rejected Hearts previously rejected due to donors' age or other risk factors can now be declared viable for transplantation using pharmacological stress echo, according to research presented at EUROECHO and other Imaging Modalities 2012. The study1 was presented by Dr Tonino Bombardini from Pisa, Italy. EUROECHO and other Imaging Modalities 2012 is the annual meeting of the European Association of...

2012-12-05 12:57:18

Antiretroviral treatment, lipid lowering drugs and prevention with healthy lifestyles are needed to prevent early CVD death in children with HIV Children with HIV have a 2.5 fold increased risk of atherosclerosis, according to research1 presented at EUROECHO and other Imaging Modalities 2012. Antiretroviral treatment, lipid lowering drugs and prevention with healthy lifestyles are needed to prevent early death from cardiovascular disease. EUROECHO and other Imaging Modalities 2012 is...